PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'CHIP Centre of Excellence for Health, Immunity, and Infections, Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.\', \'Medical Research Council Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.\', \'Hennepin Healthcare Research Institute, Minneapolis, MN, USA.\', \'Department of Medicine, School of Medicine, University of Minnesota, Minneapolis, MN, USA.\', \'Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University, Durham, NC, USA.\', \'Intermountain Medical Center, Murray, UT, USA.\', \'University of Utah School of Medicine, Salt Lake City, UT, USA.\', \'The Kirby Institute, University of New South Wales Sydney, Sydney, NSW, Australia.\', \'U.S. Department of Veterans Affairs, Washington, DC, USA.\', \'Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, USA.\', \'Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.\', \'National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.\', \'Veteran Affairs Medical Center, Washington, DC, USA.\', \'School of Medicine & Health Sciences, The George Washington University, Washington, DC, USA.\', \'Infectious Diseases Department & IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Catalonia, Spain.\', \'Institute for Global Health, University College London, London, UK.\', \'St Vincent\'s Hospital Sydney, Darlinghurst, NSW, Australia.\', \'Division of Infectious Diseases, Baylor University Medical Center, Dallas, TX, USA.\', \'Leidos Biomedical Research, Inc., Frederick, MD, USA.\', \'Division of Pulmonary and Critical Care, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.\', \'Harvard Medical School, Boston, MA, USA.\', \'National Centre for Infectious Diseases, Singapore.\', \'Tan Tock Seng Hospital, Singapore.\', \'Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1177/17407745211049829
?:hasPublicationType
?:journal
  • Clinical trials (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 34632800
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3).
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all